A Giraffe Goes Into A Bar

September 1, 2014
Category: Uncategorized


A chance meeting in a bar could mean big changes for Ernie Elephant. Has Ernie finally found a way to overcome his olfactory challenges?

Share This Post

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

  • Join Suzanne Somers: Save Bioidentical Hormones
    Jul 16, 2018 1

    Join Suzanne Somers: Save Bioidentical Hormones

    ANH-USA is proud to partner with Suzanne Somers to shine a spotlight on this critical issue. If you haven't already, click the button below to urge your member of Congress to sign a letter telling the FDA to retain consumer access to compounded bioidentical hormones, and tell your senators to ...

  • FDA Push to Ban Bioidenticals Moving Forward
    May 14, 2019 32

    FDA Push to Ban Bioidenticals Moving Forward

    An update on efforts to preserve access to bioidentical hormone replacement therapy. Action Alert! We’ve been telling you about the FDA’s efforts to curtail or eliminate patient access to bioidentical hormones, as well as potential intellectual property challenges from the pharmac...

  • Adverse Event Report Labeling for Supplements — the Controversy Continues
    Oct 28, 2008 0

    Adverse Event Report Labeling for Supplements — the Controversy Continues

    In 2006, AAHF took a stand against the proposed Dietary Supplement and Non-Prescription Drug Consumer Protection legislation, now law, because we felt the bill was not in the public’s best interest. The Food, Drug, and Cosmetic Act had already been amended to require reporting of serious adverse e...

  • Will Congress Move to Help Dying Patients?
    Jan 11, 2018 2

    Will Congress Move to Help Dying Patients?

    Right to Try legislation has passed the Senate. Now it must pass the House. Action Alert! The Trickett Wendler Right to Try Act of 2017 passed the Senate and now moves to the House. It seems to have some traction. Recently the House Energy and Commerce Committee held a hearing on the issue, and...

  • FDA Renews Attack on Homeopathy
    Nov 21, 2019 212

    FDA Renews Attack on Homeopathy

    The agency is doubling down on a bad guidance that endangers access to important medicines. Action Alert! Recently, the FDA announced the withdrawal of Compliance Policy Guide 400.400, a document that had been in place since 1988 and which established the agency’s enforcement policies regarding...